Keio University

UEI
DQDXPXHA59C8
CAGE
JA029
Primary NAICS
Not on record
SAM.gov registration
Expired

Company facts

Self-certified in SAM.gov
  • Foreign Owned
  • For Profit Organization
  • Hospital
Entity structure
Other
SAM.gov registration date

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant subawards

Prime recipient Prime award Amount Awarded
Cincinnati Univ Of Amend 4 - Metabolomics and proteomics analysis to define the role of IMPDH and its regulation in cellular metabolism R01CA255331 $10,000

Similar vendors

Vendor Location Primary NAICS
University Of Yamanashi UEI TESBFEL6FKT7 Kofu, Yamanashi 611310 Colleges, Universities, and Professional Schools
National University Corporation Yokohama National University UEI QJCSCVH377Z4 Yokohama, Kanagawa Prefecture —
Takeda Pharmaceutical Company LIMITED UEI WZM4GN1RQAK9 — —
Iese Publishing UEI RFSDMN6K88P9 Pamplona, NC 238990 All Other Specialty Trade Contractors
Kindai University UEI TLLVKC5PHJC6 Higashiosaka, Osaka 611310 Colleges, Universities, and Professional Schools

About the company

Keio University is a prominent Japanese educational institution with a significant international research presence. Registered in the System for Award Management (SAM.gov) since May 31, 2010, the university is classified as a foreign-owned, for-profit organization with a hospital structure. While not holding a federal contract vehicle, Keio University has been active in receiving federal grant sub-awards, indicating its engagement in collaborative research initiatives with U.S. academic institutions.

The university's federal grant sub-awards demonstrate a focused research agenda in advanced medical and biological sciences, specifically concentrated on metabolic and cellular research related to complex medical conditions. Two recent sub-awards from the University of Cincinnati highlight Keio University's expertise in metabolomics, proteomics, and cancer research. The most recent award from April 8, 2025, involves metabolomics and proteomics analysis examining the role of IMPDH in cellular metabolism. A previous award from February 15, 2022, centered on therapeutic resistance and malignancy in glioblastomas, exploring the contribution of GTP metabolism and its regulation through IMPDH2. These grants suggest Keio University specializes in sophisticated molecular-level research with potential implications for understanding and treating complex medical conditions, particularly in oncology and cellular metabolic processes.

Quick answers

Is Keio University registered in SAM.gov?

Keio University's SAM.gov registration expired on January 4, 2023.

On GovTribe

See Keio University's full federal record

  • Similar vendors